chronic myeloid leukemia
Showing 51 - 75 of 224
Chronic Myeloid Leukemia, Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Atlanta (G-CSF mobilized CD34+ selected
No longer available
- Chronic Myeloid Leukemia
- +2 more
- G-CSF mobilized CD34+ selected cells for transplantation
-
Atlanta, GeorgiaEmory University/Winship Cancer Institute
Feb 28, 2022
Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine, Total Marrow
Terminated
- Acute Myeloid Leukemia
- +3 more
- Fludarabine
- Total Marrow Irradiation (TMI)
-
Indianapolis, IndianaIndiana University Melvin & Bren Simon Cancer Center
Feb 22, 2022
Chronic Myeloid Leukemia Trial in Saint-Étienne (Pharmaceutical intervention)
Recruiting
- Chronic Myeloid Leukemia
- Pharmaceutical intervention
-
Saint-Étienne, FranceCHU de Saint-Etienne
Feb 24, 2022
Chronic Myeloid Leukemia, Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission, Chronic Myeloid Leukemia in Remission Trial
Recruiting
- Chronic Myeloid Leukemia
- +2 more
- Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Withdrawal
- Imatinib Mesylate, Dasatinib, Nilotinib or Bosutinib Re-initiation
-
Houston, Texas
- +3 more
Jan 25, 2022
BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib
Active, not recruiting
- Chronic Myeloid Leukemia
- Dasatinib discontinuation
-
Rionero in Vulture, Potenza, Italy
- +36 more
Jan 4, 2022
Conception/Pregnancy in Adult CML Treated With Tyrosine Kinase
Recruiting
- Chronic Myeloid Leukemia
- Pregnancy
-
Rossano, Cosenza, Italy
- +51 more
Jan 4, 2022
Chronic Myeloid Leukemia, Chronic Phase, Adults Trial in Italy (Ponatinib)
Active, not recruiting
- Chronic Myeloid Leukemia
- +2 more
-
Alessandria, Italy
- +36 more
Jan 4, 2022
Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))
Completed
- Chronic Myelomonocytic Leukemia
- +4 more
- Imatinib Mesylate (Gleevec)
-
Houston, TexasUT MD Anderson Cancer Center
Dec 7, 2021
Chronic Myeloid Leukemia Trial in Italy (Venetoclax, Rituximab)
Active, not recruiting
- Chronic Myeloid Leukemia
-
Alessandria, Italy
- +30 more
Jan 3, 2022
Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)
Completed
- Chronic Myeloid Leukemia
- Omacetaxine mepesuccinate
-
Los Angeles, California
- +28 more
Dec 1, 2021
CML Any Phase of the Disease Treated With Ponatinib (Iclusig®)
Active, not recruiting
- Chronic Myeloid Leukemia
-
Saint-Pierre, Reunion, France
- +39 more
Dec 13, 2021
Treatment Free Remission, Chronic Myeloid Leukemia Trial in Turin
Recruiting
- Treatment Free Remission
- Chronic Myeloid Leukemia
-
Turin, ItalyDivision of Hematology-AO Mauriziano Hospital, University of Tur
Nov 17, 2021
Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)
Completed
- Chronic Myeloid Leukemia
- Omacetaxine mepesuccinate
-
Los Angeles, California
- +31 more
Nov 11, 2021
Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)
Terminated
- Chronic Myeloid Leukemia
- Omacetaxine mepesuccinate
-
Jacksonville, Florida
- +9 more
Nov 6, 2021
Chronic Myeloid Leukemia Trial in Germany, Netherlands (TKI discontinuation, nilotinib)
Active, not recruiting
- Chronic Myeloid Leukemia
- TKI discontinuation
- nilotinib
-
Freiburg, Baden-Württemberg, Germany
- +14 more
Nov 4, 2021
Chronic Myeloid Leukemia Trial in Worldwide (Stopping treatment with TKI)
Completed
- Chronic Myeloid Leukemia
- Stopping treatment with TKI
-
Brno, Czechia
- +49 more
Oct 29, 2021
Acute Myeloid Leukemia, Acute Lymphoid Leukemia, MDS Trial in Leiden (MDG1021 dose 1, MDG1021 dose 2, MDG1021 dose 3)
Withdrawn
- Acute Myeloid Leukemia
- +7 more
- MDG1021 dose 1
- +3 more
-
Leiden, Zuid Holland, NetherlandsLeiden University Medical Centre
Sep 30, 2021
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in Stanford (CD8+ Memory T Cell Infusion, Thiotepa, Fludarabine)
Suspended
- Acute Myeloid Leukemia
- +4 more
- CD8+ Memory T Cell Infusion
- +5 more
-
Stanford, CaliforniaStanford Medical Center
Sep 23, 2021
Iclusig PMS in CML or Ph+ALL Patients
Recruiting
- Chronic Myeloid Leukemia
- Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
-
Busan, Korea, Republic ofKosin University Gaspel Hospital
Sep 16, 2021
Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)
Completed
- Non-Hodgkin's Lymphoma
- +7 more
- Fludarabine
- +7 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 14, 2021
PD-1 and Enhances Killing pH + Leukemia Stem Cells
Recruiting
- Chronic Myeloid Leukemia
-
Guangzhou, Guangdong, ChinaDepartment of Hematology,Nanfang Hospital, Southern Medical Univ
Aug 4, 2021
Acute Myeloid Leukemia, Lymphoblastic Leukemia, Acute Leukemia Trial in Chicago (IM-TMI (3Gy), IM-TMI (6Gy), IM-TMI (9Gy))
Completed
- Acute Myeloid Leukemia
- +4 more
- IM-TMI (3Gy)
- +3 more
-
Chicago, IllinoisUniversity of Illinois at Chicago
May 18, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell
No longer available
- Acute Lymphoblastic Leukemia
- +11 more
- CD34+ enriched, T Cell Depleted donor stem cell product
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 25, 2021